Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CPH/GUBRA stock hub

CPH/GUBRA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CPH/GUBRAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.3B

Copenhagen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CPH/GUBRA

In the news

Latest news · CPH/GUBRA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E43.9

P25 14.6P50 19.5P75 24.2

Trailing P/E3.1

P25 11.8P50 20.8P75 32.9

ROE211.8

P25 -4.6P50 11.3P75 24.2

ROIC990

P25 -8.1P50 8.5P75 13.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CPH/GUBRA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

200

Groups with data

Currency

DKK

Showing 200 of 200 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Denmark
Country code	DK
Employees	300
Employees Change	40%
Employees Change Percent	15.38
Enterprise value	DKK 4.3B
Exchange	Copenhagen Stock Exchange
Financial currency	DKK
First seen	2026-05-10
Industry	Biotechnology
Isin	DK0062266474
Last refreshed	2026-05-10
Market cap	DKK 5.3B
Price	DKK 323
Price currency	DKK
Rev Per Employee	8,789,370x
Sector	Healthcare
Sic	8731
Symbol	cph/GUBRA
Website	https://www.gubra.dk

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	32.01%
EV Earnings	2.55x
EV/EBIT	2x
EV/EBITDA	1.99x
EV/FCF	2.54x
EV/Sales	1.63x
FCF yield	32.09%
Forward P/E	43.94x
P/B ratio	4.61x
P/E ratio	3.15x
P/S ratio	2x
PE Ratio3 Y	5.24x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	81.54%
EBITDA Margin	81.76%
FCF margin	64.29%
Gross margin	96.96%
Gross Profit	DKK 2.6B
Gross Profit Growth	0.61%
Gross Profit Growth Q	16.69%
Gross Profit Growth3 Y	168.92%
Gross Profit Growth5 Y	88.04%
Net Income	DKK 1.7B
Net Income Growth Years	2%
Pretax Margin	81.71%
Profit Margin	64.11%
Profit Per Employee	DKK 5.6M
Profitable Years	1
ROA	139.1
Roa5y	28.62
ROCE	174.1
ROE	211.8
Roe5y	50.16
ROIC	990
Roic5y	223

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-4.79%
Cagr3y	50.66%
EPS Growth Years	2
OCF Growth	34,017.57%
Revenue Growth	892.25x
Revenue Growth Q	-0.3x
Revenue Growth Years	3x
Revenue Growth3 Y	127.54x
Revenue Growth5 Y	66.92x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	DKK 2.73
Assets	DKK 1.3B
Cash	DKK 1.1B
Current Assets	DKK 1.2B
Current Liabilities	DKK 85.1M
Debt	DKK 107.4M
Debt EBITDA	DKK 0.05
Debt Equity	DKK 0.09
Debt FCF	DKK 0.06
Equity	DKK 1.1B
Interest Coverage	316.7
Liabilities	DKK 173.9M
Long Term Assets	DKK 159.7M
Long Term Liabilities	DKK 88.8M
Net Cash	DKK 975.5M
Net Cash By Market Cap	DKK 18.47
Net Cash Growth	199.43%
Net Debt EBITDA	DKK -0.45
Net Debt Equity	DKK -0.85
Net Debt FCF	DKK -0.58
Tangible Book Value	DKK 1.1B
Tangible Book Value Per Share	DKK 69.35
WACC	5.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	13.63
Net Working Capital	DKK 10.7M
Quick ratio	13.58
Working Capital	DKK 1.1B
Working Capital Turnover	DKK 3.57

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.78%
Dividend Growth Years	1%
Dividend per share	DKK 0
Dividend Years	1
Last Dividend	DKK 61.2

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-4.79%
200-day SMA	408.6
3Y total return	242.04%
50-day SMA	352.7
50-day SMA vs 200-day SMA	50under200
All Time High	754
All Time High Change	-57.11%
All Time High Date	2024-07-08
All Time Low	83.45
All Time Low Change	287.54%
All Time Low Date	2023-06-29
ATR	16.06
Beta	0.25
Beta1y	1.01
Beta2y	0.85
Ch YTD	-37.51
High	332.2
High52	571
High52 Date	2025-06-16
High52ch	-43.36%
Low	316
Low52	293
Low52 Date	2026-03-09
Low52ch	10.38%
Ma50ch	-8.3%
Price vs 200-day SMA	-20.86%
RSI	42.03
RSI Monthly	47.61
RSI Weekly	35.93
Sharpe ratio	0.01x
Sortino ratio	0.13
Total Return	0.78%
Tr YTD	-37.51
Tr1m	-8.39%
Tr1w	0.75%
Tr3m	-21.31%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	DKK 2.2B
Operating Income Growth	-2.33
Operating margin	81.54

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,276,779%
Net Borrowing	-9,434,000
Shares Insiders	61.57%
Shares Institutions	13.99%
Shares Out	16,333,032
Shares Qo Q	0.02%
Shares Yo Y	-0.78%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	DKK 1.7B
Average Volume	30,889.6x
Bv Per Share	70.16
CAPEX	DKK -17.2M
Ch1m	-8.39
Ch1w	0.75
Ch1y	-15.87
Ch3m	-21.31
Ch3y	202.2
Ch6m	-14.89
Change	-3.58%
Change From Open	-2.65
Close	335.4
Days Gap	-0.95
Depreciation Amortization	5,718,000
Dollar Volume	9,203,964
Earnings Date	2026-08-20
EBIT	DKK 2.2B
EBITDA	DKK 2.2B
EPS	DKK 103
F Score	7
FCF	DKK 1.7B
FCF EV Yield	39.36x
FCF Per Share	DKK 104
Financing CF	-1,014,019,000
Fiscal Year End	December
Founded	2,008
Graham Number	402.64535
Graham Upside	24.5
Income Tax	DKK 464M
Investing CF	-800,563,000
Is Primary Listing	1
Last Earnings Date	2026-02-27
Last Report Date	2025-12-31
Ma150	417.2
Ma150ch	-22.48%
Ma20	331.4
Ma20ch	-2.42%
Net CF	-102,218,000
Next Earnings Date	2026-08-20
Open	332.2
P FCF Ratio	3.12
P OCF Ratio	3.08
Payment Date	2025-07-02
Position In Range	45.68
Ppne	131,986,000
Price Date	2026-05-08
Price EBITDA	DKK 2.45
Ptbv Ratio	4.66
Relative Volume	0.92x
Revenue	2,636,811,000x
SBC By Revenue	0.36x
Share Based Comp	9,380,000
Tax By Revenue	17.6x
Tax Rate	21.54%
Tr6m	-14.89%
Volume	28,460
Z Score	35.81

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CPH/GUBRA pay a dividend?

Capital-return profile for this ticker.

Performance

CPH/GUBRA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CPH/GUBRA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+14.0%

Share of float held by funds and institutions

Insider ownership

+61.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.8%

Negative means the company is buying back shares.

Technical

CPH/GUBRA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.0

Neutral momentum band

Price vs 200-day MA

-20.9%

50/200-day relationship not available

Beta (5Y)

0.25

Less volatile than the market

Sharpe ratio

0.01

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CPH/GUBRA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cph/GUBRA stock rating?

cph/GUBRA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cph/GUBRA analysis?

The full report lives at /stocks/cph/GUBRA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cph/GUBRA?

The latest report frames cph/GUBRA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cph/GUBRA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.